SARS-CoV-2 is associated with changes in brain structure in UK Biobank
- PMID: 35255491
- PMCID: PMC9046077
- DOI: 10.1038/s41586-022-04569-5
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
Abstract
There is strong evidence of brain-related abnormalities in COVID-191-13. However, it remains unknown whether the impact of SARS-CoV-2 infection can be detected in milder cases, and whether this can reveal possible mechanisms contributing to brain pathology. Here we investigated brain changes in 785 participants of UK Biobank (aged 51-81 years) who were imaged twice using magnetic resonance imaging, including 401 cases who tested positive for infection with SARS-CoV-2 between their two scans-with 141 days on average separating their diagnosis and the second scan-as well as 384 controls. The availability of pre-infection imaging data reduces the likelihood of pre-existing risk factors being misinterpreted as disease effects. We identified significant longitudinal effects when comparing the two groups, including (1) a greater reduction in grey matter thickness and tissue contrast in the orbitofrontal cortex and parahippocampal gyrus; (2) greater changes in markers of tissue damage in regions that are functionally connected to the primary olfactory cortex; and (3) a greater reduction in global brain size in the SARS-CoV-2 cases. The participants who were infected with SARS-CoV-2 also showed on average a greater cognitive decline between the two time points. Importantly, these imaging and cognitive longitudinal effects were still observed after excluding the 15 patients who had been hospitalised. These mainly limbic brain imaging results may be the in vivo hallmarks of a degenerative spread of the disease through olfactory pathways, of neuroinflammatory events, or of the loss of sensory input due to anosmia. Whether this deleterious effect can be partially reversed, or whether these effects will persist in the long term, remains to be investigated with additional follow-up.
© 2022. The Author(s).
Conflict of interest statement
R.C. has been seconded from the University of Oxford as chief executive and principal investigator of UK Biobank, which is a charitable company. N.A. is chief scientist for UK Biobank. P.M.M. acknowledges consultancy fees from Novartis and Biogen; he has received recent honoraria or speakers’ honoraria and research or educational funds from Novartis, Bristol Myers Squibb and Biogen. P.M.M. serves as the honorary chair of the UK Biobank Imaging Working Group and as an unpaid member of the UK Biobank Steering Committee; he is chair of the UKRI Medical Research Council Neurosciences and Mental Health Board.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig3_HTML.gif)
![Extended Data Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig4_ESM.gif)
![Extended Data Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig5_ESM.gif)
![Extended Data Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig6_ESM.gif)
![Extended Data Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig7_ESM.gif)
![Extended Data Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig8_ESM.gif)
![Extended Data Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9046077/bin/41586_2022_4569_Fig9_ESM.gif)
Update of
-
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.medRxiv [Preprint]. 2022 Mar 2:2021.06.11.21258690. doi: 10.1101/2021.06.11.21258690. medRxiv. 2022. Update in: Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. PMID: 34189535 Free PMC article. Updated. Preprint.
Comment in
-
Brain changes after COVID revealed by imaging.Nature. 2022 Apr;604(7907):633-634. doi: 10.1038/d41586-022-00503-x. Nature. 2022. PMID: 35260835 No abstract available.
-
Brain changes after COVID-19 - how concerned should we be?Nat Rev Neurol. 2022 Jun;18(6):321-322. doi: 10.1038/s41582-022-00661-6. Nat Rev Neurol. 2022. PMID: 35449462 Free PMC article.
-
COVID and smell loss: answers begin to emerge.Nature. 2022 Jun;606(7915):631-632. doi: 10.1038/d41586-022-01589-z. Nature. 2022. PMID: 35681006 No abstract available.
-
SARS-CoV-2 infection and the brain: direct evidence for brain changes in milder cases.Signal Transduct Target Ther. 2022 Jul 11;7(1):230. doi: 10.1038/s41392-022-01072-1. Signal Transduct Target Ther. 2022. PMID: 35817774 Free PMC article. No abstract available.
Similar articles
-
Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study.PLoS One. 2022 Sep 29;17(9):e0273704. doi: 10.1371/journal.pone.0273704. eCollection 2022. PLoS One. 2022. PMID: 36173949 Free PMC article.
-
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.Trends Mol Med. 2022 Sep;28(9):781-794. doi: 10.1016/j.molmed.2022.06.005. Epub 2022 Jun 20. Trends Mol Med. 2022. PMID: 35810128 Free PMC article. Review.
-
Olfactory loss and brain connectivity after COVID-19.Hum Brain Mapp. 2022 Apr 1;43(5):1548-1560. doi: 10.1002/hbm.25741. Epub 2022 Jan 27. Hum Brain Mapp. 2022. PMID: 35083823 Free PMC article.
-
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.medRxiv [Preprint]. 2022 Mar 2:2021.06.11.21258690. doi: 10.1101/2021.06.11.21258690. medRxiv. 2022. Update in: Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. PMID: 34189535 Free PMC article. Updated. Preprint.
-
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28. Neurol Sci. 2020. PMID: 32725449 Free PMC article. Review.
Cited by
-
Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome.Sci Rep. 2024 Jun 5;14(1):12927. doi: 10.1038/s41598-024-63071-2. Sci Rep. 2024. PMID: 38839833 Free PMC article.
-
COVID-19 and long-term impact on symptoms and Health-Related Quality of Life in Costa Rica: the RESPIRA cohort study.BMC Infect Dis. 2024 Jun 4;24(1):557. doi: 10.1186/s12879-024-09450-6. BMC Infect Dis. 2024. PMID: 38834971 Free PMC article.
-
Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte.Cell Mol Neurobiol. 2024 Jun 1;44(1):48. doi: 10.1007/s10571-024-01482-5. Cell Mol Neurobiol. 2024. PMID: 38822888 Free PMC article.
-
SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).PLoS One. 2024 May 30;19(5):e0295891. doi: 10.1371/journal.pone.0295891. eCollection 2024. PLoS One. 2024. PMID: 38814888 Free PMC article.
-
SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer's Disease.Curr Issues Mol Biol. 2024 May 10;46(5):4565-4579. doi: 10.3390/cimb46050277. Curr Issues Mol Biol. 2024. PMID: 38785545 Free PMC article.
References
MeSH terms
Grants and funding
- MC_PC_12028/MRC_/Medical Research Council/United Kingdom
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- ZIA MH002781/ImNIH/Intramural NIH HHS/United States
- MR/T033371/1/MRC_/Medical Research Council/United Kingdom
- G0300622/MRC_/Medical Research Council/United Kingdom
- MC_PC_12027/MRC_/Medical Research Council/United Kingdom
- MR/K006673/1/MRC_/Medical Research Council/United Kingdom
- MC_PC_21051/MRC_/Medical Research Council/United Kingdom
- MC_PC_18026/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- MC_U137686854/MRC_/Medical Research Council/United Kingdom
- MC_EX_G0801669/MRC_/Medical Research Council/United Kingdom
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- ZIA MH002782/ImNIH/Intramural NIH HHS/United States
- MR/S034978/1/MRC_/Medical Research Council/United Kingdom
- 203139/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- 215573/Z/19/Z/WT_/Wellcome Trust/United Kingdom
- MC_PC_17223/MRC_/Medical Research Council/United Kingdom
- CH/1996001/9454/BHF_/British Heart Foundation/United Kingdom
- MC_PC_15067/MRC_/Medical Research Council/United Kingdom
- MC_PC_12029/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous